US 9475862
Neutralizing GP41 antibodies and their use
granted A61KA61K2039/505A61K39/42
Quick answer
US patent 9475862 (Neutralizing GP41 antibodies and their use) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Oct 20 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Oct 25 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 20 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 22
- CPC classes
- A61K, A61K2039/505, A61K39/42, A61K45/06, A61K49/0004